awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38245669-1AB13EB9-D3B2-4145-A77F-6CABE9339F32
Q38245669-1AB13EB9-D3B2-4145-A77F-6CABE9339F32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38245669-1AB13EB9-D3B2-4145-A77F-6CABE9339F32
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer.
P2860
Q38245669-1AB13EB9-D3B2-4145-A77F-6CABE9339F32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38245669-1AB13EB9-D3B2-4145-A77F-6CABE9339F32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf954d4e63798db3a9ad6c3d8b4f7950bb8efd3c
P2860
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib